Clinical Trial Update: Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study [Phase 2, Phase 3]

View source ↗

Summary

A rollover extension study of KT-301 in chronic kidney disease stage 4 is being evaluated for long-term safety and efficacy, following the US-APR2020-01 trial. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• KT-301

Snippet

Sponsor: Kibow Pharma | Conditions: Chronic Kidney Disease stage4 | Phase 2, Phase 3 | Status: SUSPENDED